Neurology and the bone marrow

Journal of Neurology Neurosurgery and Psychiatry

Volumn 63, Issue 6, 1997, Pages 706-718

  Pollard, J D ^a,c   Young, G A R ^b  

^a Institute of Clinical Neurosciences   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; IMMUNOSUPPRESSIVE AGENT; STEROID;

BONE MARROW TRANSPLANTATION; BRAIN DYSFUNCTION; BRAIN METASTASIS; CANCER SURVIVAL; CELL PROLIFERATION; CRYOGLOBULINEMIA; HUMAN; INTRATHECAL DRUG ADMINISTRATION; LYMPHOMA; MULTIPLE MYELOMA; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPROTEINEMIA; PERIPHERAL NEUROPATHY; PLASMA CELL; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SPINAL CORD COMPRESSION; SPINAL CORD DISEASE; WALDENSTROEM MACROGLOBULINEMIA;

EID: 0030663527     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.63.6.706     Document Type: Review

References (129)

1. Silverstein A, Doniger DE. Neurological complications of myelomatosis. Arch Neurol 1963;9:534-44.
2. Woo E, Yu YL, Ng M, et al. Spinal cord compression in multiple myeloma: who gets it? Aust N Z J Med 1986;16:671-5.
3. Alexanian R. Diagnosis and management of multiple myeloma. In: Wiernik PH, et al, eds. Neoplastic diseases of the blood. New York: Churchill Livingstone, 1991:453-65.
4. Bergsagel DE, Pruzanski W. Syndromes and special presentations associated with plasma cell neoplasia. In: Wiernik PH, et al, eds. Neoplastic diseases of the blood. New York: Churchill Livingstone, 1991:485-500.
5. Spaar FW. Paraproteinaemias and multiple myeloma. In: Vinken PJ, et al, eds. Handbook of clinical neurology. Amsterdam: North Holland, 1980:131-81.
6. Henson RA, Ulrich H. Peripheral neuropathy associated with malignant disease. In: Vinken PJ, et al, eds. Handbook of clinical neurology. Amsterdam: North Holland, 1970: 131-48.
7. Walsh JC. The neuropathy of multiple myeloma. An electrophysiological and histological study. Arch Neurol 1971;25: 404-14.
8. Kelly JJ Jr, Kyle RA, Miles JM, O'Brien PC, Dyck PJ. The spectrum of peripheral neuropathy in myeloma. Neurology 1981;31:24-31.
9. Kyle RA, Dyck PJ. Neuropathy associated with monoclonal gammopathies. In: Dyck PJ, et al, eds. Peripheral neuropathy. Philadelphia: WB Saunders, 1997:1275-87.
10. Betourne C, Buge A, Dechy H, et al. The treatment of peripheral neuropathies in a case of IgA myeloma and one of mixed cryoglobulinaemia. Repeated plasmapheresis. Nouvelle Presse Medicale 1980;9:1369-71.
11. Vital C, Vallat JM, Deminiere C, et al. Peripheral nerve damage during multiple myeloma and Waldenstrom's macroglobulinemia: an ultrastructural and immunopathologic study. Cancer 1982;50:1491-7.
12. Bardwick PA, Zvaifler NJ, Gill GN, et al. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine 1980; 59:311-22.
13. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 1984;34:712-20.
14. Takatsuki K, Sanada I. Plasma cell dyscrasia with polyneuropathy and endocrine disorder: clinical and laboratory features of 109 reported cases. Jap J Clin Onc 1983;13; 543-55.
15. Gherardi RK, Chouaib S, Malapert D, et al. Early weight loss and high serum tumor necrosis factor-alpha levels in polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome. Ann Neurol 1994;35:501-5.
16. Kelly JJ Jr, Kyle RA, Miles JM, et al. Osteosclerotic myeloma and peripheral neuropathy. Neurology 1983;33:202-10.
17. Donaghy M, Hall P, Gawler J, et al. Peripheral neuropathy associated with Castleman's disease. J Neurol Sci 1989;89: 253-67.
18. Driedger H, Pruzanski W. Plasma cell neoplasia with osteosclerotic lesions. A study of five cases and a review of the literature. Arch Int Med 1979;139:892-6.
19. Stewart PM, McIntyre MA, Edwards CRW. The endocrinopathy of POEMS syndrome. Scott Med J 1989;34:520-6.
20. Mallory A, Spink WW. Angiomatous lymphoid hamartoma in the retroperitoneum presenting with neurologic signs in the legs. Ann Intern Med 1968;69:305-8.
21. Yu GS, Carson JW. Giant lymph-node hyperplasia, plasma-cell type, of the mediastinum, with peripheral neuropathy. Am J Clin Pathol 1976;66:46-53.
22. Chazot G, Berger B, Carrier H, et al. Neurological manifestations in monoclonal gammapathies. Pure neurological manifestations. Immunofluorescence study. Rev Neurol 1976;132:195-212.
23. Dhib-Jalbut S, Liwnicz BH. Binding of serum IgA of multiple myeloma to normal peripheral nerve. Acta Neurol Scand 1986;73:381-7.
24. Garrett IR, Durie BG, Nedwin GE, et al. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. N Engl J Med 1987;317:526-32.
25. Kawano M, Yamamoto I, Iwato K, et al. Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma. Blood 1989;73:1646-9.
26. Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989;74:1360-7.
27. Judge MR, McGibbon DH, Thompson RP. Angioendotheliomatosis associated with Castleman's lymphoma and POEMS syndrome. Clin Exp Dermatol 1993;18:360-2.
28. Spies J, Bonner JG, Westland KW, et al. Blood nerve barrier breakdown by activated P2 specific T cells. Brain 1995;118:857-68.
29. Sherman WH, Olarte MR, McKiernan G, et al. Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia. J Neurol Neurosurg Psychiatry 1984;47:813-9.
30. Davidson S. Solitary myeloma with peripheral polyneuropathy - recovery after treatment. Calf Med 1972; 116:68-71.
31. Berkovic SF, Scarlett JD, Symington GR, et al. Proximal motor neuropathy, dermato-endocrine syndrome, and IgG kappa paraproteinemia. Arch Neurol 1986;43:845-8.
32. Kahn SN, Riches PG, Kohn J. Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins. J Clin Pathol 1980;33:617-21.
33. Latov N, Sherman WH, Nemi R. Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral nerve myelin. N Engl J Med 1980;303:618-21.
34. Kahn SN, Smith IA, Eames RA, et al. IgM paraproteinemia and autoimmune peripheral neuropathy [letter]. N Engl J Med 1981;304:1430-1.
35. Leibowitz S, Gregson NA, Kennedy M, et al. IgM paraproteins with immunological specificity for a Schwann cell component and peripheral nerve myelin in patients with polyneuropathy. J Neurol Sci 1983;59:153-65.
36. Smith IS, Kahn SN, Lacey BW, et al. Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. Brain 1983;106:169-95.
37. Meier C, Vandevelde M, Steck A, et al. Demyelinating polyneuropathy associated with monoclonal IgM-paraproteinaemia. Histological, ultrastructural and immunocytochemical studies. J Neurol Sci 1984;63:353-67.
38. Gosselin S, Kyle RA, Dyck PJ. Neuropathy associated with monoclonal gammopathies of undetermined significance [comments]. Ann Neurol 1991;30:54-61.
39. Yeung KB, Thomas PK, King RH, et al. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol 1991;238:383-91.
40. Kelly JJ Jr, Kyle RA, O'Brien PC, et al. Prevalence of monoclonal protein in peripheral neuropathy. Neurology 1981;31: 1480-3.
41. Kaku DA, England JD, Sumner AJ. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 1994;117:941-7.
42. Pollard JD, McLeod JG, Feeney D. Peripheral neuropathy in IgM kappa paraproteinaemia. Clinical and ultrastructural studies in two patients. Clin Exp Neurol 1985;21:41-54.
43. Trapp BD, Quarles RH. Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin. J Cell Biol 1982;92:877-82.
44. Rebai T, Mhiri C, Heine P, et al. Focal myelin thickenings in a peripheral neuropathy associated with IgM monoclonal gammopathy. Acta Neuropathol 1989;79:226-32.
45. Dalakas MC, Engel WK. Polyneuropathy with monoclonal gammopathy studies of 11 patients. Ann Neurol 1981;10: 45-52.
46. Braun PE, Frail DE, Latov N. Myelin associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J Neurochem 1982;39:1261-5.
47. Nemni R, Galassi G, Latov N, et al. Polyneuropathy in nonmalignant IgM plasma cell dyscrasia: a morphological study. Ann Neurol 1983;14:43-54.
48. Steck AJ, Murray N, Meier C, et al. Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein. Neurology 1983;33:19-23.
49. Ilyas AA, Quarles RH, MacIntosh TD, et al. IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. Proc Natl Acad Sci USA 1984;81: 1225-9.
50. Bollensen E, Schachner M. The peripheral myelin glycoprotein P0 expresses the L2/HNK-1 and L3 carbohydrate structures shared by neural adhesion molecules. Neurosci Lett 1987;82:77-82.
51. Sorkin BC, Hoffman S, Edelman GM, et al. Sulfation and phosphorylation of the neural cell adhesion molecule, N-CAM. Science 1984;225:1476-8.
52. Miescher GC, Steck AJ. Paraproteinemic neuropathies. In: Hartung H, ed. Baillieres Clin Neurol 1996:219-44.
53. Latov N. Antibodies to glycoconjugates in neurological disease. Clinical Aspects of Autoimmunity 1990;4:18-29.
54. Freddo L, Yu RK, Latov N, et al. Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology 1986;36:454-8.
55. Latov N, Hays AP, Donofrio PD, et al. Monoclonal IgM with unique reactivity to gangliosides GM1 and GD1b and to lacto-N-tetraose in two patients with motor neuron disease. Neurology 1988;38:763-8.
56. Pestronk A, Li F, Griffin J. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology 1991;41:357-62.
57. Arai M, Yoshino H, Kusano Y, et al. Ataxic polyneuropathy and anti-Pr2 IgM kappa M proteinemia. J Neurol 1992;239:147-51.
58. Sherman WH, Latov N, Hays AP, et al. Monoclonal IgM kappa antibody precipitating with chondroitin sulfate C from patients with axonal polyneuropathy and epidermolysis. Neurology 1983;33:192-201.
59. Hays AP, Latov N, Takatsu M, et al. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology 1987;37:242-56.
60. Tatum AH. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann Neurol 1993;33:502-6.
61. Bleasel AF, Hawke SH, Pollard JD, et al. IgG monoclonal paraproteinaemia and peripheral neuropathy. J Neurol Neurosurg Psychiatry 1993;56:52-7.
62. Fazio R, Nemni R, Quattrini A, et al. IgG monoclonal proteins from patients with axonal peripheral neuropathies bind to different epitopes of the 68 kDa neurofilament protein. J Neuroimmunol 1992;36:97-104.
63. Bosch EP, Ansbacher LE, Goeken JA, et al. Peripheral neuropathy associated with monoclonal gammopathy. Studies of intraneural injections of monoclonal immunoglobulin sera. J Neuropathol Exp Neurol 1982;41:446-59.
64. Nobile-Orazio E, Barbieri S, Baldini L, et al. Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies. Acta Neurol Scand 1992;85:383-90.
65. Hays AP, Roxas A, Sadiq SA, et al. A monoclonal IgA in a patient with amyotrophic lateral sclerosis reacts with neurofilaments and surface antigen on neuroblastoma cells. J Neuropathol Exp Neurol 1990;49:383-98.
66. Dyck PJ, Low PA, Windebank AJ, et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance [comments]. N Engl J Med 1991;325:1482-6.
67. Thomas PK, Willison HJ. Paraproteinemic neuropathies. In: McLeod JG, ed. Baillieres Clin Neurol 1994:128-17.
68. Nobile-Orazio E. Multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 1996;60:599-603.
69. Logothetis J, Silverstein P, Coe J. Neurologic aspects of Waldenstrom's macroglobulinemia. Arch Neurol 1960;3: 564-73.
70. MacKenzie MR. Macroglobulinemia. In: Wiernik PH, et al, eds. Neoplastic diseases of the blood. New York: Churchill Livingstone, 1991:501-11.
71. Bing J, Neel AV. two cases of hyperglobulinemia and affection of the nervous system. Acta Med Scand 1936;83: 492-506.
72. MacKenzie MR, Fudenberg HH. Macroglobulinemia: an analysis for 40 patients. Blood 1972;39:874-89.
73. Bing J, Fog M, Neel AV. Reports of a third case of hyperglobulinemia with affection of the central nervous system on a toxic-infectious basis. Acta Med Scand 1937;91:409-27.
74. Bauer M, Bergstrom R, Ritter B, et al. Macroglobulinemia Waldenstrom and motor neuron syndrome. Acta Neurol Scand 1977;55:245-50.
75. Vital C, Deminiere C, Bourgouin B, et al. Waldenstrom's macroglobulinemia and peripheral neuropathy: deposition of M-component and kappa light chain in the endoneurium. Neurology 1985;35:603-6.
76. Nobile-Orazio E, Marmiroli P, Baldini L, et al. Peripheral neuropathy in macroglobulinemia: incidence and antigen-specificity of M proteins. Neurology 1987;37:1506-14.
77. Meier C, Roberts K, Steck AJ, et al. Polyneuropathy in Waldenstrom's macroglobulinemia: reduction of endoneurial IgM deposits after treatment with chlorambucil and plasmapheresis. Acta Neuropathol 1984;64:297-307.
78. Vital C, Henry P, Loiseau P, et al. Peripheral neuropathies in Waldenstrom's disease. Histological and ultrastructural studies of 5 cases. Ann Anal Path 1975;20:93-108.
79. Kyle RA, Garton JP. Immunoglobulins and laboratory recognition of monoclonal proteins. In: Wiernik PH, et al, eds. Neoplastic diseases of the blood. New York: Churchill Livingstone, 1991:373-93.
80. Apartis E, Leger JM, Musset L, et al. Peripheral neuropathy associated with essential mixed cyroglobulinemia: a role for hepatitis C virus? J Neurol Neurosurg Psychiatry 1996;60: 661-6.
81. Hutchinson JH, Howell RA. Cryoglobulinemia. Report of a case associate with digital gangrene. Ann Intern Med 1953; 38:350-7.
82. Hodson AK, Doughty RA, Norman ME. Acute encephalopathy, streptococcal infection, and cryoglobulinemia. Arch Neurol 1978;35:43-4.
83. Logothetis J, Kennedy WR, Ellington A, et al. Cryoglobulinemic neuropathy. Incidence and clinical characteristics. Arch Neurol 1968;19:389-97.
84. Abramsky O, Herishanu Y, Lavy S. Cryoglobulinemia and cerebrovascular accident. Confinia Neurologica 1971;33: 291-6.
85. Butler WR, Palmer JA. Cyroglobulinemia in polyarteritis nodosa with gangrene of extremities. Can Med Assoc J 1955;72:686-8.
86. Vallat JM, Desproges-Gotteron R, Leboutet MJ, et al. Cryoglobulinemic neuropathy: a pathological study. Ann Neurol 1980;8:179-85.
87. Garcia-Bragado F, Fernandez JM, Navarro C, et al. Peripheral neuropathy in essential mixed cryoglobulinemia. Arch Neurol 1988;45:1210-4.
88. Gemignani F, Pavesi G, Fiocchi A, et al. Peripheral neuropathy in essential mixed cryoglobulinaemia. J Neurol Neurosurg Psychiatry 1992;55:116-20.
89. Nemni R, Corbo M, Fazio R, et al. Cryoglobulinaemic neuropathy. A clinical, morphological and immunocytochemical study of 8 cases. Brain 1988;111:541-52.
90. Konishi T, Saida K, Ohnishi A, et al. Perineuritis in mononeuritis multiplex with cryoglobulinemia. Muscle Nerve 1982;5:173-7.
91. Abramsky O. Neurologic manifestation of macroglobulinemia. In: Vinken PJ, et al, eds. Handbook of clincal neurology, part 11. Amsterdam: North Holland, 1980:184-8.
92. Recht L, Straus DJ, Cirrincione C, et al. Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis. Am J Med 1988;84:425-35.
93. MacKintosh FR, Colby TV, Podolsky WJ, et al. Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases. Cancer 1982;49:586-95.
94. Paleologos NA. Disorders of white blood cells. In: Goetz CG, et al, eds. Handbook of clinical neurology. Systemic diseases. Amsterdam: Elsevier, 1993:345-67.
95. Griffin JW, Thompson RW, Mitchinson MJ, et al. Lymphomatous leptomeningitis. Am J Med 1971;51:200-8.
96. Henson RA, Urich H. Cancer and the nervous system. London: Blackwell, 1982.
97. Cairncross JG, Posner JB. Neurological complications of malignant lymphoma. In: Vinken PJ, et al, eds. Handbook of clinical neurology. Amsterdam: Elsevier, 1980:27-62.
98. Posner JB, Chernik NL. Intracranial metastases from systemic cancer. In: Shoenberg BS, ed. Advances in neurology. New York: Raven Press, 1978:575-86.
99. McDonald JV, Burton R. Subdural effusion in Hodgkin's disease. Arch Neurol 1966;15:649-52.
100. Lisak RP, Mitchell M, Zweiman B, et al. Guillain-Barre syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol 1977;1:72-8.
101. McLeod JG. Peripheral neuropathy associated with lymphomas, leukemias and polycythemia vera. In: Dyck PJ, et al, eds. Peripheral neuropathy. Philadelphia: WB Saunders, 1993:1591-8.
102. Harati Y, Niakan E. The clinical spectrum of inflammatory-angiopathic neuropathy. J Neurol Neurosurg Psychiatry 1986;49:1313-6.
103. Schold SC, Cho ES, Somasundaram M, et al. Subacute motor neuronopathy: a remote effect of lymphoma. Ann Neurol 1979;5:271-87.
104. Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med 1994;121:769-85.
105. Knowles DM. Etiology and pathogenesis of AIDS-related non-Hodgkins lymphoma. Hematol Oncol Clin North Am 1996;10:1081-9.
106. Cinque P, Brytting M, Vago L, et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993;342:398-401.
107. Sparano JA. Treatment of AIDS-related lymphomas. Curr Opin Oncol 1995;7:442-9.
108. Davis DG, Patchell RA. Neurologic complications of bone marrow transplantation. Neurol Clinics 1988;6:377-87.
109. Elfenbein GJ, Anderson PN, Humphrey RL, et al. Immune system reconstitution following allogeneic bone marrow transplantation in man: a multiparameter analysis. Trans Proc 1976;8:641-6.
110. Pier N, Dubowitz V. Chronic graft versus host disease presenting with polymyositis. Br Med J Clin Res 1983; 286:2024.
111. Schmidley JW, Galloway P. Polymyositis following autologous bone marrow transplantation in Hodgkin's disease. Neurol 1990;40:1003-4.
112. Nelson KR, McQuillen MP. Neurologic complications of graft-versus-host disease. Neurol Clin 1988;6:389-403.
113. Maguire H, August C, Sladky J. Chronic inflammatory demyelinating polyneuropathy: a previously unreported complicaction of bone marrow transplantation. Neurology 1989;39:410
114. Amato AA, Barohn RJ, Sahenk Z, et al. Polyneuropathy complicating bone marrow and solid organ transplantation. Neurology 1993;43:1513-8.
115. Rouah E, Gruber R, Shearer W, et al. Graft-versus-host disease in the central nervous system. A real entity? Am J Clin Pathol 1988;89:543-6.
116. Hickey WF, Kimura H. Graft v host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system. Proc Natl Acad Sci USA 1987;84:2082-6.
117. Walker RW, Allen JC, Rosen G, et al. Transient cerebral dysfunction secondary to high-dose methotrexate. J Clin Oncol 1986;4:1845-50.
118. Bleyer WA, Griffin TW. White matter necrosis mineralizing microangiopathy and intellectual abilities in survivors of childhood leukemia: associations with central nervous system irradiation and methotrexate therapy. In: Gilbert HA, et al, eds. Radiation damage to the nervous system: a delayed therapeutic hazard. New York: Raven Press, 1980:155-74.
119. Carmel RJ, Kaplan HS. Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications. Cancer 1976;37:2813-25.
120. Somasundaram M, Posner JB. Neurological complications of Hodgkin's disease. In: Lachner MJ, ed. Hodgkin's disease. New York: John Wiley, 1976.
121. Chernik NL, Armstrong D, Posner JB. Central nervous system infections in patients with cancer. Medicine 1973;52:563-81.
122. Lukes SA, Posner JB, Nielsen S, et al. Bacterial infections of the CNS in neutropenic patients. Neurology 1984;34: 269-75.
123. Goffinet DR, Glatstein EJ, Merigan TC. Herpes zoster - varicella infections and lymphoma. Ann Int Med 1972;76: 235-40.
124. Pruitt AA. Central nervous system infections in cancer patients. In: Patchell RA, ed. Neurologic clinics. Philadelphia: WB Saunders, 1991:867-88.
125. Richardson EP. Progressive multifocal leukoencephalopathy. In: Vinken PJ, et al. Handbook of clinical neurology. Amsterdam: North-Holland, 1970:485-99.
126. Astrom KE, Mancall EL, Richardson EP. Progressive multifocal leukoencephalopathy. A hitherto unrecognised complication of chronic lymphatic leukemia and Hodgkin's disease. Brain 1958;81:93-111.
127. Robertson GL, Bhoopalam N, Zelkowitz LJ. Vincristine neurotoxicity and abnormal secretion of antidiuretic hormone. Arch Intern Med 1973;132:717-20.
128. Winkelman MD, Hines JD. Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study. Ann Neurol 1983;14:520-7.
129. McLeod JG, Penny R. Vincristine neuropathy: an electrophysiological and histological study. J Neurol Neurosurg Psychology 1969;32:297-304.